Nuala Moran

One of Europe's leading life sciences investors is pulling out to focus on larger, lower-risk private equity buyouts of profitable mid-size biotechs.

The DETECT-it 2 project aims to find opportunities for SMEs to participate in the first call of the 7th Framework Programme.

Two of Europe’s gene therapy pioneers have reported significant progress in the last week, bringing commercial gene therapy products yet closer to reality.

Europe’s small biotechs have leapt to take advantage of the European Medicines Agency’s (EMEA) office for SMEs, according to a review of its first year in operation.

The UK government has published its latest set of research papers outlining the future for science and technology and future issues and trends in other fields over the next fifty years.

The Czech Republic became a full member of the European Southern Observatory on 1 January, following a signing ceremony in Prague in December.

Seven of London’s leading medical research institutions created an independent company to broker partnerships in the field of genetics and genomics.

The latest OECD research on Japan provides a warning to Europe that merely spending more does not make innovation spring forth.

Industry in Europe and elsewhere will need to act in concert to apply the recommendations iof the report into the disastrous TGN 1412 drugs trial.

Transport | Aviation | Energy | Airbus | United Kingdom